Table 2.
Clinical Characteristics of Study Sample by Diagnosis
| IBD (N=95) | IBS (N=80) | |
|---|---|---|
| Diagnosis Years | 13.7 (10.3) | 10.0 (9.0) |
| HBI (CD Only)a | 4.4 (3.7) | - |
| SCCAI (UC Only)a | 3.4 (2.8) | - |
| IBS-SSS | - | 221.7 (73.2) |
| In Remissionb | 61% (58)* | 0% |
| Currently Using Medication | 85% (81) | 76% (61) |
| Biologics | 50% (47) | - |
| Corticosteroids | 18% (17) | - |
| Immunomodulators | 26% (25) | - |
| Probiotics | - | 24% (19) |
| Antispasmodics | - | 14% (11) |
| Laxatives | - | 24% (19) |
| Other | 44% (34) | 33% (26) |
| Currently Using Diet | 64% (61) | 81% (65)* |
| Single Diet Use | 32% (30) | 44% (36) |
| Multiple Diet Use | 33% (31) | 36% (29) |
| Dietitian Visit | 41% (39)* | 35% (20) |
*
P < .01
a
IBD diagnosis is presented as Crohn’s Disease (CD) and ulcerative colitis (UC) due to different symptom severity scales used.
b
Remission status based on accepted cutoff scores for Harvey Bradshaw Index (HBI), Simple Colitis Clinical Activity Index (SCCAI), and IBS-Symptom Severity Scale (IBS-SSS).